CDKN2A and neoplasm: Some tumours with wild type RB1 have shown to exhibit chromothripsis, where alternative mechanisms of RB1 deregulation, such as overexpression/amplification of cyclin D1 (CCD1) and/or inactivation of cyclin dependent kinase inhibitor 2A (CDKN2A), have been identified [6,8].